Evidence map›Paper›PMID 34698544›Full record

ArticleScience progress2021

Development and criterion validity of the COVID-19 anxiety and fear assessment scale: a cross sectional study.

Juan Gómez-Salgado, Regina Allande-Cussó, Carmen Rodríguez-Domínguez, Sara Domínguez-Salas, Selena Camacho-Martín, Adolfo Romero Ruiz, Carlos Ruiz-Frutos

Abstract read
In one paragraph

Article in Science progress, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Juan Gómez-SalgadoDepartment of Sociology, Social Work and Public Health, Faculty of Labour Sciences, 16743University of Huelva, Spain.ORCID 0000-0001-9053-7730
Regina Allande-CussóDepartment of Nursing, 16778University of Seville, Spain.ORCID 0000-0001-8325-0838
Carmen Rodríguez-DomínguezDepartment of Psychology, 376603Universidad Loyola Andalucía, Spain.
Sara Domínguez-SalasDepartment of Psychology, 376603Universidad Loyola Andalucía, Spain.ORCID 0000-0002-5666-1487
Selena Camacho-MartínAndalusian Health Service, Juan Ramón Hospital in Huelva, Spain.
Adolfo Romero RuizDepartment of Nursing and Podiatry, Health Sciences School, 16752University of Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Spain.
Carlos Ruiz-FrutosDepartment of Sociology, Social Work and Public Health, Faculty of Labour Sciences, 16743University of Huelva, Spain.ORCID 0000-0003-3715-1382

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe emergence of the new severe acute respiratory syndrome coronavirus 2, which causes COVID-19 disease, has been a major public health challenge and an increase in the feeling of uncertainty of the population, who is also experiencing an increase in levels of anxiety and fear regarding the COVID-19 disease.

objectiveThe objective of the study was the construct and criterion validation of the

methodsDescriptive study of psychometric validation. A field study was carried out to execute univariate and bivariate analyses, in addition to the exploratory and confirmatory factorial analysis of the scale. For the criteria validity study, the

resultsThe study sample was composed of 1036 subjects over 18 years of age, who resided in Spain, where 56.3% were women with a mean age of 48.11 years (SD = 15.13). The study of construct validity reported two factors and 16 items, with a Cronbach's alpha value of 0.92. The scale was concurrently valid with the used gold standard and obtained sensitivity values of 90.48% and specificity values of 76%.

conclusionsThe AMICO scale is valid and reliable for assessing the level of anxiety and fear of COVID-19 in the adult Spanish population and is highly sensitive.

Indexed as

COVID-19AdolescentAdultAnxietyCross-Sectional StudiesFearFemaleHumansMiddle AgedReproducibility of ResultsSARS-CoV-2anxietyCOVID-19Fearinstrument developmentmental healthpublic health

Identifiers

PMID34698544
PMCPMC10306143

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.